{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,8]],"date-time":"2025-07-08T04:05:33Z","timestamp":1751947533286,"version":"3.41.2"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,7,7]]},"DOI":"10.7759\/cureus.87410","type":"journal-article","created":{"date-parts":[[2025,7,7]],"date-time":"2025-07-07T08:30:36Z","timestamp":1751877036000},"source":"Crossref","is-referenced-by-count":0,"title":["Intractable Vomiting as an Initial and Evasive Presentation of Neuromyelitis Optica Spectrum Disorder"],"prefix":"10.7759","author":[{"given":"Sally","family":"Wirrom-Jorrie","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anara","family":"Karaca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlos","family":"Canessa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","unstructured":"Muscle disorders affecting oral and pharyngeal swallowing. (2006). Accessed. July 7, 2025: https:\/\/www.nature.com\/gimo\/contents\/pt1\/full\/gimo35.html."},{"key":"ref2","article-title":"Evaluation of nausea and vomiting","volume":"76","author":"Scorza K","year":"2007","unstructured":"Scorza K, Williams A, Phillips JD, Shaw J. Evaluation of nausea and vomiting. Am Fam Physician. 2007, 76:76-84.","journal-title":"Am Fam Physician"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1111\/ene.14385","article-title":"Dysphagia, dysarthria and aphasia following a first acute ischaemic stroke: incidence and associated factors","volume":"27","author":"De Cock E","year":"2020","unstructured":"De Cock E, Batens K, Hemelsoet D, Boon P, Oostra K, De Herdt V. Dysphagia, dysarthria and aphasia following a first acute ischaemic stroke: incidence and associated factors. Eur J Neurol. 2020, 27:2014-21. 10.1111\/ene.14385","journal-title":"Eur J Neurol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1186\/s42466-021-00122-3","article-title":"Diagnosis and treatment of neurogenic dysphagia - S1 guideline of the German Society of Neurology","volume":"3","author":"Dziewas R","year":"2021","unstructured":"Dziewas R, Allescher HD, Aroyo I, et al.. Diagnosis and treatment of neurogenic dysphagia - S1 guideline of the German Society of Neurology. Neurol Res Pract. 2021, 3:23. 10.1186\/s42466-021-00122-3","journal-title":"Neurol Res Pract"},{"key":"ref5","article-title":"Facial weakness, dysarthria, and dysphagia","author":"Tarulli A","year":"2010","unstructured":"Tarulli A. Facial weakness, dysarthria, and dysphagia. Neurology: A Clinician\u2019s Approach. Cambridge University Press, Cambridge, England; 2010. 62-8."},{"key":"ref6","article-title":"Dysarthria","author":"O\u2019Sullivan SB","year":"2024","unstructured":"O\u2019Sullivan SB, Schmitz TJ. Dysarthria. Motor Speech Disorders: Substrates, Differential Diagnosis, and Management. Duffy JR (ed): Elsevier Mosby, St. Louis, MI; 2024."},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1177\/1756285617709723","article-title":"Differential diagnosis of neuromyelitis optica spectrum disorders","volume":"10","author":"Kim SM","year":"2017","unstructured":"Kim SM, Kim SJ, Lee HJ, Kuroda H, Palace J, Fujihara K. Differential diagnosis of neuromyelitis optica spectrum disorders. Ther Adv Neurol Disord. 2017, 10:265-89. 10.1177\/1756285617709723","journal-title":"Ther Adv Neurol Disord"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000001729","article-title":"International consensus diagnostic criteria for neuromyelitis optica spectrum disorders","volume":"85","author":"Wingerchuk DM","year":"2015","unstructured":"Wingerchuk DM, Banwell B, Bennett JL, et al.. International consensus diagnostic criteria for neuromyelitis optica spectrum disorders. Neurology. 2015, 85:177-89. 10.1212\/WNL.0000000000001729","journal-title":"Neurology"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1006\/frne.1994.1012","article-title":"The area postrema and vomiting","volume":"15","author":"Miller AD","year":"1994","unstructured":"Miller AD, Leslie RA. The area postrema and vomiting. Front Neuroendocrinol. 1994, 15:301-20. 10.1006\/frne.1994.1012","journal-title":"Front Neuroendocrinol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1590\/S0004-282X2012000100023","article-title":"Atypical presentations of neuromyelitis optica","volume":"69","author":"Sato D","year":"2011","unstructured":"Sato D, Fujihara K. Atypical presentations of neuromyelitis optica. Arq Neuropsiquiatr. 2011, 69:824-8. 10.1590\/S0004-282X2012000100023","journal-title":"Arq Neuropsiquiatr"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1186\/s12883-016-0721-1","article-title":"The role of anti-aquaporin 4 antibody in the conversion of acute brainstem syndrome to neuromyelitis optica","volume":"16","author":"Cheng C","year":"2016","unstructured":"Cheng C, Jiang Y, Lu X, et al.. The role of anti-aquaporin 4 antibody in the conversion of acute brainstem syndrome to neuromyelitis optica. BMC Neurol. 2016, 16:203. 10.1186\/s12883-016-0721-1","journal-title":"BMC Neurol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.2147\/NDT.S147360","article-title":"Complexity and wide range of neuromyelitis optica spectrum disorders: more than typical manifestations","volume":"13","author":"Han J","year":"2017","unstructured":"Han J, Yang MG, Zhu J, Jin T. Complexity and wide range of neuromyelitis optica spectrum disorders: more than typical manifestations. Neuropsychiatr Dis Treat. 2017, 13:2653-60. 10.2147\/NDT.S147360","journal-title":"Neuropsychiatr Dis Treat"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000010059","article-title":"A case report of neuromyelitis optica spectrum disorder with peripheral neuropathy as the first episode","volume":"97","author":"Chi LM","year":"2018","unstructured":"Chi LM, Gao Y, Nan GX. A case report of neuromyelitis optica spectrum disorder with peripheral neuropathy as the first episode. Medicine (Baltimore). 2018, 97:e0059. 10.1097\/MD.0000000000010059","journal-title":"Medicine (Baltimore)"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.nerep.2021.100021","article-title":"Pruritus as initial symptom of neuromyelitis optica spectrum disorder: a Peruvian case report","volume":"1","author":"Rivera\u2011Valdivia A","year":"2021","unstructured":"Rivera\u2011Valdivia A, Meza\u2011Vega M, Segura Chavez D, Castro\u2011Suarez S. Pruritus as initial symptom of neuromyelitis optica spectrum disorder: a Peruvian case report. Neuroimmunol Rep. 2021, 1:100021. 10.1016\/j.nerep.2021.100021","journal-title":"Neuroimmunol Rep"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1177\/1352458512457720","article-title":"Neuropathic pruritus (itch) in neuromyelitis optica","volume":"19","author":"Elsone L","year":"2013","unstructured":"Elsone L, Townsend T, Mutch K, Das K, Boggild M, Nurmikko T, Jacob A. Neuropathic pruritus (itch) in neuromyelitis optica. Mult Scler. 2013, 19:475-9. 10.1177\/1352458512457720","journal-title":"Mult Scler"},{"key":"ref16","article-title":"Comparative analysis of treatment outcomes in patients with neuromyelitis optica spectrum disorder treated with rituximab, azathioprine, and mycophenolate mofetil: a systematic review and meta-analysis","volume":"19","author":"Magdalena C","year":"2022","unstructured":"Magdalena C, Clarissa A, Sutandi N. Comparative analysis of treatment outcomes in patients with neuromyelitis optica spectrum disorder treated with rituximab, azathioprine, and mycophenolate mofetil: a systematic review and meta-analysis. Innov Clin Neurosci. 2022, 19:51-64.","journal-title":"Innov Clin Neurosci"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.3988\/jcn.2013.9.1.36","article-title":"Clinical efficacy of plasmapheresis in patients with neuromyelitis optica spectrum disorder and effects on circulating anti-aquaporin-4 antibody levels","volume":"9","author":"Kim SH","year":"2013","unstructured":"Kim SH, Kim W, Huh SY, Lee KY, Jung IJ, Kim HJ. Clinical efficacy of plasmapheresis in patients with neuromyelitis optica spectrum disorder and effects on circulating anti-aquaporin-4 antibody levels. J Clin Neurol. 2013, 9:36-42. 10.3988\/jcn.2013.9.1.36","journal-title":"J Clin Neurol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/378463-intractable-vomiting-as-an-initial-and-evasive-presentation-of-neuromyelitis-optica-spectrum-disorder","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,7]],"date-time":"2025-07-07T08:30:37Z","timestamp":1751877037000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/378463-intractable-vomiting-as-an-initial-and-evasive-presentation-of-neuromyelitis-optica-spectrum-disorder"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,7]]},"references-count":17,"URL":"https:\/\/doi.org\/10.7759\/cureus.87410","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7,7]]}}}